Zydus Lifesciences on Tuesday said its offer to buy back 59.7 lakh shares at Rs 1,005 apiece, aggregating to Rs 600 crore, will open on February 29.
The share repurchase programme will close on March 6, 2024, the drug firm said in a regulatory filing.
The company proposed to buy back up to 59,70,149 shares at Rs 1,005 apiece for an aggregate consideration not exceeding Rs 600 crore, it stated.
Shares of the company were trading 0.38% up at Rs 946.15 apiece on the BSE.
ADVERTISEMENT
RECOMMENDED FOR YOU

Blackstone Unit Launches Rs 5,335 Crore Open Offer For 26% Stake In Aadhar Housing


Bajaj Consumer Mulls Second Share Buyback In A Year


SML Isuzu Acquisition: How M&M's Open Offer May Fare For Investors


Tanla Platforms Share Buyback: Past Acceptance Ratios And 2025 Offer Details
